Tolterodine Tartrate Tablet, Film Coated
Product Images NDC 31722-806

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 31722-806). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber (Camber)

FDA Label Image

Structure (Structure)

Chemical structure of Tolterodine Tartrate, showing the molecular arrangement including aromatic rings, methyl groups, and tartrate moiety (C4H6O6).*

FDA Label Image

Table-1 (Table 1)

Pharmacokinetic data table presenting Tolterodine and its 5-Hydroxymethyl Metabolite parameters by CYP2D6 phenotype (EM and PM). Parameters include tmax, Cmax, Cavg, t1/2, and CL/F for single and multiple doses, showing values with standard deviations in mcg/L, hours, and L/h.*

FDA Label Image

Table-2 (Table 2)

A data table comparing QTcF and QTcP intervals in milliseconds measured manually and by machine for Tolterodine tablets at 2 mg and 4 mg doses taken twice daily (BID), and Moxifloxacin 400 mg taken once daily (QD). The table includes sample sizes (N) and interval values with ranges in parentheses.*

FDA Label Image

Table-3 (Table 3)

A data table comparing Tolterodine tartrate tablets and placebo across three measures: number of incontinence episodes per week, number of micturitions per 24 hours, and volume voided per micturition in milliliters. The table includes mean baseline values, mean changes from baseline with standard deviations, and differences with 95% confidence intervals for each parameter.*

FDA Label Image

Table-4 (Table 4)

A data table titled 'Table 4. 95% Confidence Intervals (CI) for the Difference between Tolterodine Tartrate Tablets (2 mg bid) and Placebo for the Mean Change at Week 12 from Baseline in Studies 008, 009, 010.' It presents comparative study data for Tolterodine Tartrate 2 mg tablets versus placebo, including the number of patients, mean baseline, mean change from baseline, and confidence intervals for incontinence episodes, micturitions, and volume voided per micturition across three clinical studies.*

FDA Label Image

Toltcontlabel1mg60s (Toltcontlabel1mg60s)

Packaging label for Tolterodine Tartrate Tablets 1 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label indicates 60 tablets per bottle and includes dosage, storage, and manufacturer information along with a barcode. Label also notes Rx only status.*

FDA Label Image

Toltcontlabel2mg60s (Toltcontlabel2mg60s)

Packaging label for Tolterodine Tartrate Tablets 2 mg film-coated tablets. The label shows the product strength, quantity of 60 tablets, and manufacturer details including Camber Pharmaceuticals, Inc. and Annora Pharma Pvt. Ltd. It includes storage instructions, a U.S. contact number, and a barcode. The label features branding with the Camber Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.